| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,551 |
7,619 |
$885K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,332 |
5,751 |
$468K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,165 |
1,164 |
$165K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
381 |
381 |
$36K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
252 |
233 |
$11K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
113 |
113 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
1,073 |
1,049 |
$7K |
| 0011A |
|
54 |
54 |
$2K |
| 0012A |
|
30 |
30 |
$1K |
| 87428 |
|
31 |
29 |
$825.87 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
67 |
64 |
$813.32 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
43 |
41 |
$741.06 |
| 80061 |
Lipid panel |
50 |
49 |
$587.50 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
12 |
$544.06 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
58 |
56 |
$485.08 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
16 |
16 |
$412.47 |
| 96127 |
|
55 |
55 |
$218.76 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$198.71 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$176.40 |
| 90686 |
|
14 |
14 |
$172.99 |
| 81025 |
|
13 |
13 |
$99.58 |
| 91301 |
|
91 |
91 |
$0.00 |